Research News

---

Topic: Targeted Therapies (view all topics)

Tags for topic Targeted Therapies:

• Adjuvant
• Afinitor
• Avastin
• Herceptin
• Iniparib
• Neoadjuvant
• Perjeta (chemical name: pertuzumab; aka Omnitarg)
• T-DM1
• Tykerb

View articles by month and year

• New Studies Show Avastin Provides Little Benefit for Breast Cancer

  Published on December 17, 2012 at 9:23 am

  • Tags: Avastin

  More research shows that Avastin offers few benefits in treating breast cancer.

• Large Review Study Says Avastin Offers Only Modest Benefits for Metastatic Breast Cancer

  Published on July 11, 2012 at 12:00 am

  • Tags: Avastin

  Results from a new large review study show that Avastin offers only modest benefits for stopping the growth and spread of metastatic breast cancer.

• Afinitor Before Surgery Doesn’t Help Treat HER2-Negative Breast Cancer

  Published on December 11, 2011 at 12:00 am

  • Tags: Abraxane (chemical name: paclitaxel), Cytoxan (chemical name: cyclophosphamide), Ellence (chemical name: epirubicin), Taxol (chemical name: paclitaxel), Standard, Neoadjuvant, Afinitor, Avastin, and Neoadjuvant

  Research has found that adding Afinitor to paclitaxel didn't improve the response to neoadjuvant treatment with paclitaxel in women diagnosed with advanced-stage, HER2-negative breast cancer.

• Adding Avastin Slows Growth of Metastatic, HER2-Positive Disease

  Published on December 8, 2011 at 12:00 am

  • Tags: Avastin and Herceptin

  A study has found that adding Avastin (chemical name: bevacizumab) to a combination of Herceptin (chemical name: trastuzumab) and Taxotere (chemical name: docetaxel) increased the likelihood of respond...

• FDA Removes Breast Cancer Indication from Avastin

  Published on November 18, 2011 at 12:00 am

  • Tags: Avastin

  On Nov. 18, 2011 FDA Commissioner Margaret Hamburg decided to remove the breast cancer indication from Avastin.

• Blue Shield of California Will No Longer Pay for Avastin to Treat Advanced-Stage Breast Cancer

  Published on October 3, 2011 at 12:00 am

  • Tags: Avastin

  Blue Shield of California has announced it will no longer pay for bevacizumab (Avastin) to treat advanced breast cancer. This is the largest insurer to stop coverage since an FDA panel voted that the drug's breast cancer indication should be removed.

• Avastin Plus Taxol May Help Treat Metastatic, Triple-Negative Disease

  Published on September 30, 2011 at 12:00 am

  • Tags: Avastin

  Some women diagnosed with triple-negative metastatic breast cancer benefit from a combination of Avastin and Taxol.

• National Comprehensive Cancer Network Continues Support of Avastin for Metastatic Breast Cancer

  Published on July 27, 2011 at 12:00 am

  • Tags: Avastin

  The National Comprehensive Cancer Network continues to support Avastin to treat certain metastatic breast cancers.

• Medicare Will Continue Paying for Avastin to Treat Metastatic Breast Cancer

  Published on June 30, 2011 at 12:00 am

  • Tags: Avastin

  Medicare has announced that it will continue to pay for Avastin to treat metastatic breast cancer.

• FDA Expert Panel Recommends Removing Breast Cancer Indication from Avastin

  Published on June 29, 2011 at 12:00 am

  • Tags: Avastin

  An FDA advisory committee unanimously recommended that Avastin should no longer be approved to treat metastatic, HER2-negative breast cancer.